ÂÜÀòÂÒÂ×

Annegret de Baey-Diepolder is an experienced board member and consultant in the life sciences sector, currently serving on the Board of Directors for Cytoki Pharma, Abalos Therapeutics GmbH, and Dopavision GmbH, while also holding the position of Venture Partner at Seventure Partners since April 2017. With a strong background in interim management and fundraising through de Baey Science to Business Consulting, Annegret has also contributed as a Board Observer at Tubulis GmbH and previously as a Board Member at Humedics GmbH. Leadership roles included serving as Interim CEO of Ugichem and CEO of Rigontec, and ImmunOligo. Annegret holds a Medical Doctor degree with a specialization in Dermatology, Allergology, and Immunology from the Technical University of Munich.